ICU MED INC's ticker is ICUI and the CUSIP is 44930G107. A total of 289 filers reported holding ICU MED INC in Q4 2021. The put-call ratio across all filers is 6.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1,893,826 | +734.3% | 10,702 | +970.2% | 0.00% | – |
| Q1 2022 | $227,000 | -89.9% | 1,000 | -89.4% | 0.00% | -100.0% |
| Q4 2021 | $2,251,000 | -28.2% | 9,406 | -29.3% | 0.00% | 0.0% |
| Q3 2021 | $3,137,000 | +458.2% | 13,298 | +391.8% | 0.00% | +200.0% |
| Q1 2021 | $562,000 | +14.0% | 2,704 | +17.4% | 0.00% | 0.0% |
| Q4 2020 | $493,000 | -61.1% | 2,303 | -66.7% | 0.00% | -66.7% |
| Q3 2020 | $1,268,000 | -8.0% | 6,922 | -9.6% | 0.00% | -25.0% |
| Q2 2020 | $1,379,000 | -75.6% | 7,655 | -73.3% | 0.00% | -76.5% |
| Q1 2020 | $5,642,000 | +263.1% | 28,661 | +241.9% | 0.02% | +325.0% |
| Q4 2019 | $1,554,000 | +17.9% | 8,384 | -0.5% | 0.00% | 0.0% |
| Q3 2019 | $1,318,000 | -18.8% | 8,430 | +46.8% | 0.00% | +33.3% |
| Q3 2018 | $1,623,000 | +0.7% | 5,743 | -55.5% | 0.00% | -62.5% |
| Q3 2016 | $1,612,000 | +591.8% | 12,900 | +514.3% | 0.01% | +700.0% |
| Q2 2016 | $233,000 | – | 2,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EVR Research LP | 22,000 | $4,719,000 | 3.86% |
| NUANCE INVESTMENTS, LLC | 901,483 | $193,359,000 | 3.73% |
| Nitorum Capital, L.P. | 417,241 | $89,494,000 | 3.46% |
| Tamarack Advisers, LP | 73,000 | $15,452,000 | 3.22% |
| PFM Health Sciences, LP | 267,817 | $57,444,000 | 2.02% |
| KIRR MARBACH & CO LLC /IN/ | 22,222 | $4,766,000 | 1.49% |
| PURA VIDA INVESTMENTS, LLC | 174,399 | $37,407,000 | 1.36% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 2,584 | $554,000 | 0.88% |
| Findlay Park Partners LLP | 528,825 | $113,428,000 | 0.79% |
| Altium Capital Management LP | 9,321 | $1,999,000 | 0.75% |